Form D · Biotechnology
Tivic Health Systems, Inc.
Fremont, CA · CIK 0001787740
Offering snapshot reported Dec 29, 2025 · SEC filing
- Reported sold
- $12M Offering amount: $75M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 10, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 29, 2025 | Initial | $12,000,000 | No comparison | 5 | SEC filing |
| Dec 29, 2025 | Initial | $16,253,147 | No comparison | 1 | SEC filing |
| Sep 10, 2019 | Initial | $7,899,667 | No comparison | 66 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-568271
Securities include preferred stock and warrants.
Source: Form D, filed Dec 29, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sheryle Bolton | Director |
| John Claude | Director, Promoter |
| Jennifer Ernst | Director, Executive, Promoter |
| Michael Handley | Executive |
| Christina Valauri | Director |
| Lisa Wolf | Executive |
| Dean Zikria | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
47685 Lakeview Blvd
Fremont, CA, 94538
Fremont, CA, 94538